Study identifier:NIS-RRU-DUM-2010/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Non-interventional retrospective multicenter study of patients with bronchial asthma during a routine visit to out of patients' clinics
asthma
-
No
-
All
1000
Observational
18 Years +
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Dec 2013 by AstraZeneca Pharmaceuticals
AstraZeneca Pharmaceuticals
-
To assess asthma control in Russian patients according to the new criteria provided in the international guidelines and identify pharmacological approaches that provide a higher level of overall asthma control
Location
Location
Moscow, Russian Federation
Location
St.Petersburg, Russian Federation
Location
Novosibirsk, Russian Federation
Location
Irkutsk, Russian Federation
Location
Krasnoyarsk, Russian Federation
Location
Perm, Russian Federation
Location
Chelyabinsk, Russian Federation
Location
Krasnodar, Russian Federation
Arms | Assigned Interventions |
---|---|
1 Male and female over 18. Patients with asthma diagnosed in accordance with the Global Initiative for Asthma within 6 months before inclusion into the study and without changes in treatment for 2 months before inclusion | - |
This information is not intended to replace the informed medical advice or medical treatments of a healthcare professional. Only a physician can determine if a specific medicine is the correct treatment for a particular patient. If you have questions regarding any information contained in this site, you must consult a suitably qualified healthcare professional. Before prescribing any AstraZeneca products, Healthcare Professionals should view their country specific information.